BIO Announces DuPont CEO Ellen Kullman to Receive the 2014 BIO George Washington Carver Award

  BIO Announces DuPont CEO Ellen Kullman to Receive the 2014 BIO George
  Washington Carver Award

   Ellen Kullman, Chair of the Board & Chief Executive Officer for DuPont,
              Honored for Innovation in Industrial Biotechnology

2014 World Congress on Industrial Biotechnology

Business Wire

WASHINGTON -- March 13, 2014

The Biotechnology Industry Organization (BIO) named DuPont Chair & CEO Ellen
Kullman as the recipient of its 2014 George Washington Carver Award for
innovation in industrial biotechnology. Kullman is the first woman to receive
the honor, which has been awarded annually since 2008.

“Ellen is always looking for opportunities to apply today’s breaking science
to major global challenges where biotechnology can deliver new gains,” said
Brent Erickson, executive vice president for BIO’s Industrial & Environmental
Section. “BIO is pleased to honor Ellen for her efforts to drive
commercialization of industrial biotech processes and renewable, sustainable
biobased products. We look forward to future advances in this field from
DuPont under her leadership.”

“I am honored to receive this award on behalf of all of the people who have
worked to make DuPont a leader in industrial biotechnology,” said Kullman.
“For more than 200 years DuPont has transformed industries through scientific
innovation. That tradition continues today with industrial biotechnology, a
21st century scientific discipline that is helping us improve our customers’
products and make industrial processes more sustainable.”

A special selection committee chose Kullman for her drive to grow DuPont’s
industrial biotechnology business. Kullman has been leading change at DuPont
for the last five years, driving advances in the company’s portfolio and
operational capabilities. DuPont’s diverse portfolio has been carefully formed
by Kullman to address worldwide trends stemming from rapidly growing
populations and demand for healthy food, clean energy and greater protection
of people and the environment.

As CEO, Ellen has championed innovation across the company’s businesses and
focuses DuPont’s formidable research capabilities on the needs of the world’s
markets. She is widely recognized as a global business leader who is
transforming this historic science company from its heritage in explosives in
the 19^th century, through the chemical innovations of the 20^th century and
now into an integrated science company with broad capabilities in
biotechnology. Under her leadership DuPont has made significant progress in
commercializing biobased polymers, enzymes and advanced biofuels. Later this
year, DuPont will commission one the world’s first and largest cellulosic
ethanol facilities in Iowa, helping establish the United States as the global
leader in advanced renewable fuel technology and commercialization.

“This award serves as a lasting memorial to the vision of George Washington
Carver who, over a century ago, started the ‘chemurgy’ movement and pioneered
the creation and commercialization of renewable and sustainable bioproducts
and materials made from agricultural feedstocks,” Erickson said. “Ellen’s
commitment to creating a biobased economy carries on the great enterprise of
George Washington Carver.”

Ms. Kullman will be presented the award and will deliver a brief keynote
address during the Tuesday, May 13^th plenary lunch session at BIO’s 11th
Annual World Congress on Industrial Biotechnology, the world’s largest
industrial biotech conference. The conference is being held at the
Pennsylvania Convention Center in Philadelphia, Pennsylvania, May 12 – 15,

Past winners of the annual award have demonstrated significant accomplishments
in innovation or business development and have employed industrial
biotechnology to facilitate the advancement of a biobased economy and
industrial sustainability and include:

  *Dr. Patrick Gruber, CEO of Gevo, Inc., in 2008;
  *Charles O. Holliday, Jr., chairman of the board of DuPont in 2009;
  *Gregory Stephanopoulos, the Willard Henry Dow Professor of Chemical
    Engineering at Massachusetts Institute of Technology in 2010;
  *Feike Sijbesma, CEO of Royal DSM in 2011;
  *Steen Riisgaard, president and CEO of Novozymes in 2012; and
  *Dr. Jay Keasling, a professor of biochemical engineering at University of
    California, Berkeley in 2013.

All World Congress sessions are open to credentialed media. Complimentary
media registration is available to editors and reporters with valid press
credentials working full time for print, broadcast or web publications.
Pre-registration for reporters is now open.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions,
state biotechnology centers and related organizations across the United States
and in more than 30 other nations. BIO members are involved in the research
and development of innovative healthcare, agricultural, industrial and
environmental biotechnology products. BIO also produces the BIO International
Convention, the world’s largest gathering of the biotechnology industry, along
with industry-leading investor and partnering meetings held around the world.
BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling
“innovations transforming our world.” Subscribe to BIOtechNOW.

Upcoming BIO Events

BIO Asia International Conference
April 8-9, 2014
Tokyo, Japan

World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA

BIO International Convention
June 23-26, 2014
San Diego, CA

Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD


Biotechnology Industry Organization (BIO)
Caitlin G. Kennedy, 202-312-9288
Twitter: @IAmBiotech, #BIOWorldCongress
Press spacebar to pause and continue. Press esc to stop.